Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, United States.
J Am Chem Soc. 2013 Feb 6;135(5):1749-59. doi: 10.1021/ja307710d. Epub 2013 Jan 18.
Nocardicin A is a monocyclic β-lactam isolated from the actinomycete Nocardia uniformis that shows moderate antibiotic activity against a broad spectrum of gram-negative bacteria. The monobactams are of renewed interest due to emerging gram-negative strains resistant to clinically available penicillins and cephalosporins. Like isopenicillin N, nocardicin A has a tripeptide core of non-ribosomal origin. Paradoxically, the nocardicin A gene cluster encodes two non-ribosomal peptide synthetases (NRPSs), NocA and NocB, predicted to encode five modules pointing to a pentapeptide precursor in nocardicin A biosynthesis, unless module skipping or other nonlinear reactions are occurring. Previous radiochemical incorporation experiments and bioinformatic analyses predict the incorporation of p-hydroxy-L-phenylglycine (L-pHPG) into positions 1, 3, and 5 and L-serine into position 4. No prediction could be made for position 2. Multidomain constructs of each module were heterologous expressed in Escherichia coli for determination of the adenylation domain (A-domain) substrate specificity using the ATP/PPi exchange assay. Three of the five A-domains, from modules 1, 2, and 4, required the addition of stoichiometric amounts of MbtH family protein NocI to detect exchange activity. On the basis of these analyses, the predicted product of the NocA and NocB NRPSs is L-pHPG-L-Arg-D-pHPG-L-Ser-L-pHPG, a pentapeptide. Despite being flanked by non-proteinogenic amino acids, proteolysis of this pentapeptide by trypsin yields two fragments from cleavage at the C terminus of the L-Arg residue. Thus, a proteolytic step is likely involved in the biosynthesis of nocardicin A, a rare but precedented editing event in the formation of non-ribosomal natural products that is supported by the identification of trypsin-encoding genes in N. uniformis.
诺卡菌素 A 是一种从诺卡氏放线菌中分离得到的单环β-内酰胺,对广谱革兰氏阴性菌具有中等抗生素活性。由于出现了对临床可用的青霉素和头孢菌素耐药的革兰氏阴性菌株,单内酰胺类抗生素再次受到关注。与异青霉素 N 一样,诺卡菌素 A 具有非核糖体起源的三肽核心。矛盾的是,诺卡菌素 A 基因簇编码两个非核糖体肽合酶 (NRPSs),NocA 和 NocB,预计编码五个模块,指向诺卡菌素 A 生物合成中的五肽前体,除非发生模块跳过或其他非线性反应。先前的放射性化学掺入实验和生物信息学分析预测将 p-羟基-L-苯甘氨酸 (L-pHPG) 掺入位置 1、3 和 5,以及 L-丝氨酸掺入位置 4。对于位置 2 无法做出预测。每个模块的多域构建体都在大肠杆菌中异源表达,用于使用 ATP/PPi 交换测定法确定腺苷酸结构域 (A-结构域) 底物特异性。五个 A-结构域中的三个,来自模块 1、2 和 4,需要添加化学计量量的 MbtH 家族蛋白 NocI 才能检测到交换活性。基于这些分析,NocA 和 NocB NRPSs 的预测产物是 L-pHPG-L-Arg-D-pHPG-L-Ser-L-pHPG,一种五肽。尽管被非蛋白质氨基酸侧翼,但胰蛋白酶对该五肽的蛋白水解在 L-Arg 残基的 C 末端切割产生两个片段。因此,生物合成诺卡菌素 A 可能涉及一个蛋白水解步骤,这是在非核糖体天然产物形成中罕见但有先例的编辑事件,这得到了在 N. uniformis 中鉴定出的胰蛋白酶编码基因的支持。